Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.68 USD | +2.34% | -5.18% | +16.16% |
May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Business Summary
Number of employees: 102
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transformative Cell and Exosome-based Therapeutics
100.0
%
| 3 | 100.0 % | 25 | 100.0 % | +886.81% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 25 | 100.0 % | +886.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 13-11-19 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 13-11-19 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Karen Krasney
LAW | General Counsel | 71 | 11-12-31 |
General Counsel | 71 | 15-02-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 23-07-20 |
Earl Collier
BRD | Director/Board Member | 76 | 13-11-19 |
George Dunbar
BRD | Director/Board Member | 77 | 13-11-19 |
David Musket
BRD | Director/Board Member | 66 | 13-11-19 |
Frank Litvack
CHM | Chairman | 68 | 11-12-31 |
Karimah Es Sabar
BRD | Director/Board Member | 66 | 21-07-22 |
Linda Marbán
CEO | Chief Executive Officer | 60 | 13-11-19 |
Paul Auwaerter
BRD | Director/Board Member | 62 | 23-07-12 |
Michael Kelliher
BRD | Director/Board Member | 47 | 23-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,811,470 | 29,183,127 ( 91.74 %) | 0 | 91.74 % |
Company contact information
Capricor Therapeutics, Inc.
10865 Road to the Cure Suite 150
92121, San Diego
+858 727 1755
http://www.capricor.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.16% | 181M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CAPR Stock
- Company Capricor Therapeutics, Inc.